{"id":4238,"date":"2026-03-05T11:15:09","date_gmt":"2026-03-05T11:15:09","guid":{"rendered":"https:\/\/nhsdorset.nhs.uk\/medicines\/?page_id=4238"},"modified":"2026-03-11T11:53:00","modified_gmt":"2026-03-11T11:53:00","slug":"insulin-glargine","status":"publish","type":"page","link":"https:\/\/nhsdorset.nhs.uk\/medicines\/value\/insulin-glargine\/","title":{"rendered":"Insulin glargine biosimilar switch"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1310.4px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p><span class=\"TextRun SCXW181997937 BCX8\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"none\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW181997937 BCX8\">Semglee<\/span><span class=\"NormalTextRun SCXW181997937 BCX8\"> biosimilar as the best value insulin glargine biosimilar.<\/span><\/span><\/p>\n<\/div><div class=\"accordian fusion-accordian\" style=\"--awb-border-size:1px;--awb-icon-size:18px;--awb-content-font-size:var(--awb-typography4-font-size);--awb-icon-alignment:left;--awb-hover-color:var(--awb-color2);--awb-border-color:var(--awb-color3);--awb-background-color:var(--awb-color1);--awb-divider-color:var(--awb-color3);--awb-divider-hover-color:var(--awb-color3);--awb-icon-color:var(--awb-color5);--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);--awb-icon-box-color:var(--awb-color5);--awb-toggle-hover-accent-color:var(--awb-color4);--awb-toggle-active-accent-color:var(--awb-color4);--awb-title-font-family:var(--awb-typography1-font-family);--awb-title-font-weight:var(--awb-typography1-font-weight);--awb-title-font-style:var(--awb-typography1-font-style);--awb-title-font-size:20px;--awb-content-font-family:var(--awb-typography4-font-family);--awb-content-font-weight:var(--awb-typography4-font-weight);--awb-content-font-style:var(--awb-typography4-font-style);\"><div class=\"panel-group fusion-toggle-icon-unboxed\" id=\"accordion-4238-1\"><div class=\"fusion-panel panel-default panel-022a8ad7c0f0c3957 fusion-toggle-no-divider fusion-toggle-boxed-mode\" style=\"--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_022a8ad7c0f0c3957\"><a aria-expanded=\"false\" aria-controls=\"022a8ad7c0f0c3957\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-4238-1\" data-target=\"#022a8ad7c0f0c3957\" href=\"#022a8ad7c0f0c3957\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon fa-capsules fas\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What work is required?<\/span><\/a><\/h4><\/div><div id=\"022a8ad7c0f0c3957\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_022a8ad7c0f0c3957\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><span data-contrast=\"none\">Semglee\u00a0is the best value, preferred long-acting insulin glargine product in Dorset. In line with\u00a0<\/span><a href=\"https:\/\/www.england.nhs.uk\/medicines-2\/biosimilar-medicines\/\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">NHSE recommendations<\/span><\/a><span data-contrast=\"none\">, PCN teams are asked to ensure that biosimilar insulin glargine (Semglee) accounts for at least 50% of all insulin glargine prescribing in primary care.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Clinical appropriateness should always be considered, and any switches should be discussed and agreed with patients through shared decision-making.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"none\">Exclusion criteria:<\/span><\/b><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">< 18 years of age<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients prescribed Lantus 100units\/ml 10ml vials<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients prescribed Lantus 100units\/ml solution for injection 3ml cartridges<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients prescribed Abasaglar 100units\/ml solution for injection 3ml cartridges<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"5\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients prescribed\u00a0Toujeo\u00a0300units\/ml solution for injection pre-filled pens<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"7\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients who are pregnant or planning to become pregnant<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"8\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients who have their insulin administered by a district nurse<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"9\" data-aria-level=\"1\"><span data-contrast=\"none\">Patients who have not had a HbA1c blood test or diabetes review in the last 12 months<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"22\" data-list-defn-props=\"{\" data-aria-posinset=\"10\" data-aria-level=\"1\"><span data-contrast=\"none\">Documented intolerance or allergy to any excipient listed in the\u00a0Semglee\u00a0SPC or have failed\u00a0a previous\u00a0trial of\u00a0Semglee<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">Extra care should be taken when considering Semglee switch for patients living with <strong>cognitive impairment, learning disability, dementia <\/strong>or<strong> Alzheimer's.<\/strong><\/span><strong>\u00a0<\/strong><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-3929abd3ef85e9867 fusion-toggle-no-divider fusion-toggle-boxed-mode\" style=\"--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_3929abd3ef85e9867\"><a aria-expanded=\"false\" aria-controls=\"3929abd3ef85e9867\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-4238-1\" data-target=\"#3929abd3ef85e9867\" href=\"#3929abd3ef85e9867\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon fa-capsules fas\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Why is this part of the contract?<\/span><\/a><\/h4><\/div><div id=\"3929abd3ef85e9867\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_3929abd3ef85e9867\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Biosimilar insulin glargine (Semglee) is now available in the UK and is significantly cheaper than Abasaglar, Lantus and generic originator insulin glargine products<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">A biosimilar medicine is a biological medicine which has been shown not to have any clinically meaningful differences from the originator medicine in terms of quality, safety and efficacy. Where NICE has already recommended the originator biological medicine, the same guidance applies to a biosimilar.\u00a0\u00a0NHS England aims to drive a step change in the uptake of biosimilar medicines by integrated care systems (ICS)<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Biosimilar insulins offer a cost-effective alternative to prescribing originator insulin products<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Switching to insulin biosimilars will help PCN\u202fteams\u00a0<\/span><span data-contrast=\"none\">care for patients within their NHS England financial envelope and\u00a0hence,re<\/span><span data-contrast=\"none\">lease funds to improve unmet needs in prevention.<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"23\" data-list-defn-props=\"{\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Early switching is recommended to maximise cumulative\u202fin year\u202fcost savings<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-805feda20c10637d4 fusion-toggle-no-divider fusion-toggle-boxed-mode\" style=\"--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_805feda20c10637d4\"><a aria-expanded=\"false\" aria-controls=\"805feda20c10637d4\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-4238-1\" data-target=\"#805feda20c10637d4\" href=\"#805feda20c10637d4\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon fa-capsules fas\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">How do I do it?<\/span><\/a><\/h4><\/div><div id=\"805feda20c10637d4\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_805feda20c10637d4\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><span data-contrast=\"none\">Notify community pharmacy colleges of the intention to switch to\u00a0Semglee\u00a0biosimilar.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Work with community pharmacy colleagues to ensure sufficient stock of\u00a0Semglee\u00a0is available to support the switching programme and minimise disruption to patients,\u00a0GP\u00a0and community pharmacy teams.\u00a0<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Run the SystmOne searches provided to identify existing patients prescribed Lantus, Abasaglar and generic insulin glargine pre-filled pen products other than Semglee pre-filled pens.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Dorset SystmOne GPs>PINH 26 27> 4a Biosimilar insulin>4d Work to do: T2DM with Insulin glargine prefilled pens RPT\u00a0 consider switching to Semglee biosimilar prefilled pens<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Dorset SystmOne GPs>PWNH 26 27> 4a Biosimilar insulin>4d Work to do: T1 diabetes with Insulin glargine prefilled pens RPT\u00a0 consider switching to Semglee biosimilar prefilled pens<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">A risk\u00a0<\/span><span data-contrast=\"none\">management<\/span><span data-contrast=\"none\">\u00a0<\/span><span data-contrast=\"none\">approach<\/span><span data-contrast=\"none\">\u00a0should be taken, to any batch-switching arrangement, which includes safeguards which enable patients to have a review, should they have any queries or changes to their condition.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Agree a patient-centred process for switching patients within the practice and convert patients accordingly.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><strong>Switch patients to the appropriate\u00a0Semglee\u00a0device as below:\u00a0\u00a0<\/strong><\/p>\n\n<div class=\"table-1\">\n<table width=\"100%\">\n<thead>\n<tr>\n<th align=\"left\"><span data-contrast=\"none\">Originator insulin<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/th>\n<th align=\"left\"><span data-contrast=\"none\">Switch to equivalent biosimilar insulin product<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td align=\"left\"><span data-contrast=\"none\">Lantus Solostar (insulin glargine) 100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/td>\n<td align=\"left\"><span data-contrast=\"none\">Prescribe\u00a0Semglee\u00a0100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td align=\"left\"><span data-contrast=\"none\">Generic insulin glargine 100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/td>\n<td align=\"left\"><span data-contrast=\"none\">Prescribe\u00a0Semglee\u00a0100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td align=\"left\"><span data-contrast=\"none\">Abasaglar\u00a0KwikPen\u00a0100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/td>\n<td align=\"left\"><span data-contrast=\"none\">Prescribe\u00a0Semglee\u00a0100units\/ml solution for injection 3ml pre-filled pens<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\n<p><span data-contrast=\"none\">Ensure all insulins including biosimilar insulins are prescribed by brand name and provide the strength or the provided insulin.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Switching a patient to\u00a0Semglee\u00a0can be done unit-to-unit based on the\u00a0previous\u00a0long-acting insulin dose.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Check patients get the intended insulin and are trained on how to use it.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Patients should continue to\u00a0monitor\u00a0their blood glucose as usual and continue to use their current insulin needles.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Encourage patients to use up existing insulin supplies prior to starting their new biosimilar insulin.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Safety net the patient to report any concerns about glucose levels to the practice diabetes team.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Update the repeat prescription template and summary care record.<\/span><\/p>\n<p><span data-contrast=\"none\">Update the patient's insulin passport.<\/span><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">For further information and advice for healthcare professionals when starting treatment with a biosimilar, the\u00a0<\/span><span data-contrast=\"none\">MHRA has guidance on minimising the risk of medication error with high-strength, fixed combination and biosimilar insulin products<\/span><span data-contrast=\"none\">, which ensures the risk of medication errors with insulins is minimised. Biosimilar insulins are black triangle drugs. <a href=\"https:\/\/yellowcard.mhra.gov.uk\/\" target=\"_blank\" rel=\"noopener\">Report any suspected adverse effects to the MHRA via the Yellow Card reporting scheme.<\/a><\/span><\/p>\n<p><span data-contrast=\"none\">Provide\u00a0appropriate counselling\u00a0where\u00a0appropriate.<\/span><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-2fe2b7183387e06f1 fusion-toggle-no-divider fusion-toggle-boxed-mode\" style=\"--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_2fe2b7183387e06f1\"><a aria-expanded=\"false\" aria-controls=\"2fe2b7183387e06f1\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-4238-1\" data-target=\"#2fe2b7183387e06f1\" href=\"#2fe2b7183387e06f1\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon fa-capsules fas\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">What resources\/support is provided to help me deliver this?<\/span><\/a><\/h4><\/div><div id=\"2fe2b7183387e06f1\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_2fe2b7183387e06f1\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><strong>How to communicate this to patients:\u00a0<\/strong><\/p>\n<p><span data-contrast=\"none\">Use the template patient text message and letter in\u00a0SystmOne\u00a0to notify patients of the change.<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><strong>Text message:\u00a0<\/strong><\/p>\n<p><span data-contrast=\"none\">\"NHS Dorset have asked GP teams to review prescriptions for insulin glargine (lantus or abasaglar) pre-filled pens and switch to a new pre-filled pen Semglee. Semglee is a biosimilar insulin used to help with cost-effectiveness and availability. Semglee is considered clinically interchangeable with other insulin glargine pens. The dosage will not change, and the insulin will work in the same way. Please use up your existing insulin supply prior to starting the new Semglee pen. Please read the patient information leaflet provided and if you have any questions regarding this change, please discuss with your Community Pharmacist or GP practice team. \"<\/span><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><strong>Template patient letter:\u00a0<\/strong><\/p>\n<p><strong>References:\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/www.england.nhs.uk\/long-read\/what-is-a-biosimilar-medicine\/\"><span data-contrast=\"none\">NHS England \u00bb What is a biosimilar medicine?<\/span><\/a><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.england.nhs.uk\/medicines-2\/biosimilar-medicines\/\"><span data-contrast=\"none\">NHS England \u00bb Biosimilar medicines<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fnhsdorset.nhs.uk%2Fwp-content%2Fuploads%2F2025%2F04%2FBiosimilar-uptake-patient-letter-template-Jul24.docx&wdOrigin=BROWSELINK\">Biosimilar uptake patient letter template<\/a><\/p>\n<p><a href=\"https:\/\/www.dorsetformulary.nhs.uk\/\"><span data-contrast=\"none\">NHS Dorset Biosimilar documents can be found on the front page of the Dorset Formulary<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.dorsetformulary.nhs.uk\/chaptersSubDetails.asp?FormularySectionID=6&SubSectionRef=06.01.01.01&SubSectionID=C100&drugmatch=5994#5994\"><span data-contrast=\"none\">Dorset Formulary<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/nhsdorset.nhs.uk\/Downloads\/aboutus\/medicines-management\/Other%20Guidelines\/Dorset%20Insulin%20Formulary%20for%20Type%201%20Type%202%20Diabetes%20in%20Adults%20Nov%2023.pdf?boxtype=pdf&g=false&s=true&s2=false&r=wide&UNLID=71293058420253311142\"><span data-contrast=\"none\">Dorset adult insulin formulary for type 1 & type 2 diabetes<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng17\/resources\/type-1-diabetes-in-adults-diagnosis-and-management-pdf-1837276469701\"><span data-contrast=\"none\">NICE NG17: type 1 diabetes in adults: diagnosis and management<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng28\/resources\/type-2-diabetes-in-adults-management-pdf-1837338615493\"><span data-contrast=\"none\">NICE NG29: type 2 diabetes in adults: management<\/span><\/a><span data-ccp-props=\"{\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.gov.uk\/drug-safety-update\/high-strength-fixed-combination-and-biosimilar-insulin-products-minimising-the-risk-of-medication-error?UNLID=7533607272016481362\"><span data-contrast=\"none\">MHRA (2015): High strength, fixed combination and biosimilar insulin products: minimising the risk of medication error<\/span><\/a><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.england.nhs.uk\/long-read\/what-is-a-biosimilar-medicine\/\"><span data-contrast=\"none\">NHS England \u00bb What is a biosimilar medicine?<\/span><\/a><span data-ccp-props=\"\">\u00a0<\/span><\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-dae8bec9dadbc1759 fusion-toggle-no-divider fusion-toggle-boxed-mode\" style=\"--awb-title-color:var(--awb-color5);--awb-content-color:var(--awb-custom_color_1);\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\" id=\"toggle_dae8bec9dadbc1759\"><a aria-expanded=\"false\" aria-controls=\"dae8bec9dadbc1759\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-4238-1\" data-target=\"#dae8bec9dadbc1759\" href=\"#dae8bec9dadbc1759\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon awb-icon-minus\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon fa-capsules fas\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">How do I calculate my progress against the target for this metric<\/span><\/a><\/h4><\/div><div id=\"dae8bec9dadbc1759\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_dae8bec9dadbc1759\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>Tracking achievement:<\/p>\n<p>Numerator divided by Denominator from SystmOne searches x 100 for %<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3067,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-4238","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/pages\/4238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/comments?post=4238"}],"version-history":[{"count":12,"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/pages\/4238\/revisions"}],"predecessor-version":[{"id":4480,"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/pages\/4238\/revisions\/4480"}],"up":[{"embeddable":true,"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/pages\/3067"}],"wp:attachment":[{"href":"https:\/\/nhsdorset.nhs.uk\/medicines\/wp-json\/wp\/v2\/media?parent=4238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}